BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25720081)

  • 21. Liquid chromatographic/tandem mass spectrometric method for the determination of the tobacco-specific nitrosamine metabolite NNAL in smokers' urine.
    Byrd GD; Ogden MW
    J Mass Spectrom; 2003 Jan; 38(1):98-107. PubMed ID: 12526011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk.
    Chung CJ; Lee HL; Yang HY; Lin P; Pu YS; Shiue HS; Su CT; Hsueh YM
    Sci Total Environ; 2011 Apr; 409(9):1638-42. PubMed ID: 21334728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPE-HPLC-MS/MS method for the trace analysis of tobacco-specific N-nitrosamines and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in rabbit plasma using tetraazacalix[2]arene[2]triazine-modified silica as a sorbent.
    Wang L; Yang C; Zhang Q; Wang S; Lang H; Zhang S; Zhao W; Zhang J
    J Sep Sci; 2013 Aug; 36(16):2664-71. PubMed ID: 23861164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined analysis of r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers' plasma.
    Carmella SG; Yoder A; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1490-4. PubMed ID: 16896038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous, rapid, and sensitive quantification of 8-hydroxy-2'-deoxyguanosine and cotinine in human urine by on-line solid-phase extraction LC-MS/MS: correlation with tobacco exposure biomarkers NNAL.
    Chen CY; Jhou YT; Lee HL; Lin YW
    Anal Bioanal Chem; 2016 Sep; 408(23):6295-306. PubMed ID: 27422644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking.
    Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P; Benowitz NL
    Nicotine Tob Res; 2011 Mar; 13(3):202-8. PubMed ID: 21330276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.
    Vardavas CI; Fthenou E; Patelarou E; Bagkeris E; Murphy S; Hecht SS; Connolly GN; Chatzi L; Kogevinas M
    Tob Control; 2013 May; 22(3):194-200. PubMed ID: 22253001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of adducts produced by the reaction of 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanol with deoxyguanosine and DNA.
    Upadhyaya P; Sturla SJ; Tretyakova N; Ziegel R; Villalta PW; Wang M; Hecht SS
    Chem Res Toxicol; 2003 Feb; 16(2):180-90. PubMed ID: 12588189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TSNA exposure from cigarette smoking: 18 years of urinary NNAL excretion data.
    Appleton S; Olegario RM; Lipowicz PJ
    Regul Toxicol Pharmacol; 2014 Mar; 68(2):269-74. PubMed ID: 23920111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass spectrometric quantitation of nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human toenails.
    Stepanov I; Feuer R; Jensen J; Hatsukami D; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2378-83. PubMed ID: 17164359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urine concentrations of a tobacco-specific nitrosamine carcinogen in the U.S. population from secondhand smoke exposure.
    Bernert JT; Pirkle JL; Xia Y; Jain RB; Ashley DL; Sampson EJ
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2969-77. PubMed ID: 20833972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fully automated analysis of four tobacco-specific N-nitrosamines in mainstream cigarette smoke using two-dimensional online solid phase extraction combined with liquid chromatography-tandem mass spectrometry.
    Zhang J; Bai R; Yi X; Yang Z; Liu X; Zhou J; Liang W
    Talanta; 2016; 146():216-24. PubMed ID: 26695255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of creatinine and specific gravity for hydration corrections on measurement of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.
    Xia Y; Wong LY; Bunker BC; Bernert JT
    J Clin Lab Anal; 2014 Sep; 28(5):353-63. PubMed ID: 24648246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine.
    Kavvadias D; Scherer G; Urban M; Cheung F; Errington G; Shepperd J; McEwan M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1185-92. PubMed ID: 19328751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma.
    Wu CC; Su CT; Lee HL; Chung CJ; Huang CY; Pu YS; Lin P; Hsueh YM
    J Urol; 2012 Nov; 188(5):1701-5. PubMed ID: 22998908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer
    Biomarkers; 2000; 5(1):33-45. PubMed ID: 23885904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary biomarkers to assess exposure of cats to environmental tobacco smoke.
    McNiel EA; Carmella SG; Heath LA; Bliss RL; Le KA; Hecht SS
    Am J Vet Res; 2007 Apr; 68(4):349-53. PubMed ID: 17397288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urine menthol as a biomarker of mentholated cigarette smoking.
    Benowitz NL; Dains KM; Dempsey D; Havel C; Wilson M; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):3013-9. PubMed ID: 20962297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of systemic carcinogen exposure in waterpipe smokers, cigarette smokers and non-smokers.
    Al Ali R; Rastam S; Ibrahim I; Bazzi A; Fayad S; Shihadeh AL; Zaatari GS; Maziak W
    Tob Control; 2015 Mar; 24(2):125-7. PubMed ID: 23988862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Goniewicz ML; Havel CM; Peng MW; Jacob P; Dempsey D; Yu L; Zielinska-Danch W; Koszowski B; Czogala J; Sobczak A; Benowitz NL
    Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3421-5. PubMed ID: 19959691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.